Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Aclaris Therapeutics Inc (ACRS)
Aclaris Therapeutics Inc (ACRS) News

ACRS

Aclaris Therapeutics (ACRS)

Aclaris Therapeutics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACRS

<< Previous 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next >>

Date	Time	Source	Headline	Symbol	Company
05/07/2018	4:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
05/07/2018	10:00AM	GlobeNewswire Inc.	Aclaris Therapeutics Announces Availability of ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w)	NASDAQ:ACRS	Aclaris Therapeutics Inc
05/02/2018	7:00AM	GlobeNewswire Inc.	Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/26/2018	5:56PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/25/2018	7:31AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/24/2018	4:05PM	GlobeNewswire Inc.	Aclaris Therapeutics Announces Appointment of Bryan Reasons as a Director and Chairman of the Audit Committee	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/24/2018	4:05PM	GlobeNewswire Inc.	Aclaris Therapeutics to Announce First Quarter 2018 Financial Results on May 8, 2018	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/23/2018	6:30PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/23/2018	6:29PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/23/2018	7:00AM	GlobeNewswire Inc.	Aclaris Therapeutics Announces First Patient Dosed in a Pilot Study with ATI-502 Topical in Patients with Androgenetic Alopec...	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/17/2018	6:18PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/09/2018	4:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/09/2018	4:52PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/09/2018	4:51PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/09/2018	8:40AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/06/2018	7:00AM	GlobeNewswire Inc.	Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical sol...	NASDAQ:ACRS	Aclaris Therapeutics Inc
04/03/2018	4:05PM	GlobeNewswire Inc.	Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/26/2018	4:49PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/22/2018	4:37PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/20/2018	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/20/2018	5:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/20/2018	5:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/20/2018	5:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/20/2018	7:00AM	GlobeNewswire Inc.	Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in Journal of Experimental Medicine	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/19/2018	8:00AM	GlobeNewswire Inc.	Aclaris Therapeutics Announces Positive Update on Phase 2 Results after a 3-month Follow-Up of A-101 45% Topical Solution for...	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/12/2018	9:14AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/12/2018	8:21AM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/12/2018	7:16AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/12/2018	7:00AM	GlobeNewswire Inc.	Aclaris Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Clinical and Commerci...	NASDAQ:ACRS	Aclaris Therapeutics Inc
03/09/2018	8:00AM	GlobeNewswire Inc.	Aclaris Therapeutics Announces Issuance of U.S. Patent Covering a JAK Inhibitor for Treating Hair Loss Disorders	NASDAQ:ACRS	Aclaris Therapeutics Inc